6FTN | pdb_00006ftn

mPI3Kd IN COMPLEX WITH AZ2


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 
    0.272 (Depositor), 0.279 (DCC) 
  • R-Value Work: 
    0.248 (Depositor), 0.251 (DCC) 
  • R-Value Observed: 
    0.249 (Depositor) 

Starting Model: other
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 6FTN

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-gamma Inhibitors.

Pemberton, N.Mogemark, M.Arlbrandt, S.Bold, P.Cox, R.J.Gardelli, C.Holden, N.S.Karabelas, K.Karlsson, J.Lever, S.Li, X.Lindmark, H.Norberg, M.Perry, M.W.D.Petersen, J.Rodrigo Blomqvist, S.Thomas, M.Tyrchan, C.Westin Eriksson, A.Zlatoidsky, P.Oster, L.

(2018) J Med Chem 61: 5435-5441

  • DOI: https://doi.org/10.1021/acs.jmedchem.8b00447
  • Primary Citation Related Structures: 
    6FTN

  • PubMed Abstract: 

    In this paper, we describe the discovery and optimization of a new chemotype of isoform selective PI3Kγ inhibitors. Starting from an HTS hit, potency and physicochemical properties could be improved to give compounds such as 15, which is a potent and remarkably selective PI3Kγ inhibitor with ADME properties suitable for oral administration. Compound 15 was advanced into in vivo studies showing dose-dependent inhibition of LPS-induced airway neutrophilia in rats when administered orally.


  • Organizational Affiliation
    • Pharmaron Beijing Co., Ltd. , No. 6 Taihe Road, BDA , Beijing 100176 , P. R. China.

Macromolecule Content 

  • Total Structure Weight: 108.14 kDa 
  • Atom Count: 6,899 
  • Modeled Residue Count: 827 
  • Deposited Residue Count: 939 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Phosphor inositol 3 kinase939Mus musculusMutation(s): 0 
EC: 2.7.1.137 (UniProt), 2.7.1.153 (UniProt)
UniProt
Find proteins for O35904 (Mus musculus)
Explore O35904 
Go to UniProtKB:  O35904
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO35904
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
E78

Query on E78



Download:Ideal Coordinates CCD File
B [auth A]~{N}-[5-[2-[(1~{S})-1-cyclopropylethyl]-7-methyl-1-oxidanylidene-3~{H}-isoindol-5-yl]-4-methyl-1,3-thiazol-2-yl]ethanamide
C20 H23 N3 O2 S
CNCRCDLWUGCPSJ-LBPRGKRZSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
E78 BindingDB:  6FTN IC50: min: 200, max: 1780 (nM) from 2 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free:  0.272 (Depositor), 0.279 (DCC) 
  • R-Value Work:  0.248 (Depositor), 0.251 (DCC) 
  • R-Value Observed: 0.249 (Depositor) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 141.227α = 90
b = 65.012β = 103.38
c = 116.341γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
MOSFLMdata reduction
Aimlessdata scaling
MOLREPphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

  • Released Date: 2018-06-20 
  • Deposition Author(s): Petersen, J.

Revision History  (Full details and data files)

  • Version 1.0: 2018-06-20
    Type: Initial release
  • Version 1.1: 2018-07-11
    Changes: Data collection, Database references
  • Version 1.2: 2024-05-01
    Changes: Data collection, Database references, Refinement description